SHPH SHUTTLE PHARMACTCLS HLDGS IN revenue, earnings and financials
For the quarter ended June 30, 2026, SHUTTLE PHARMACTCLS HLDGS IN reported revenue of n/a, net income of −$3.15M and diluted EPS of −$3.10; for the fiscal year ended December 2025 revenue was n/a.
SHPH annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$11.9M, net income −$11.7M (margin n/a), EPS −$7.16
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$7.70M, net income −$9.14M (margin n/a), EPS −$82.60
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$5.89M, net income −$6.59M (margin n/a), EPS −$3.53
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$2.34M, net income −$5.00M (margin n/a), EPS −$5.04
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$1.74M, net income −$1.15M (margin n/a), EPS n/a
SHPH quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$3.15M, EPS −$3.10
- Quarter ended Mar 31, 2026: revenue n/a, net income −$2.15M, EPS −$0.43
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$2.61M, EPS $34.40
- Quarter ended Sep 30, 2025: revenue n/a, net income −$2.35M, EPS −$1.05
- Quarter ended Jun 30, 2025: revenue n/a, net income −$3.71M, EPS −$32.91
- Quarter ended Mar 31, 2025: revenue n/a, net income −$3.05M, EPS −$7.60
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$1.60M, EPS −$17.82
- Quarter ended Sep 30, 2024: revenue n/a, net income −$3.78M, EPS −$39.83
- Quarter ended Jun 30, 2024: revenue n/a, net income −$2.03M, EPS −$24.12
- Quarter ended Mar 31, 2024: revenue n/a, net income −$1.73M, EPS −$0.83
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$1.64M, EPS −$0.82
- Quarter ended Sep 30, 2023: revenue n/a, net income −$1.79M, EPS −$0.91
- Quarter ended Jun 30, 2023: revenue n/a, net income −$2.18M, EPS −$1.23
- Quarter ended Mar 31, 2023: revenue n/a, net income −$975K, EPS −$0.57
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$2.72M, EPS n/a
- Quarter ended Sep 30, 2022: revenue n/a, net income −$998K, EPS −$0.10
- Quarter ended Jun 30, 2022: revenue n/a, net income −$597K, EPS −$0.06
- Quarter ended Mar 31, 2022: revenue n/a, net income −$682K, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$459K, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income −$217K, EPS n/a
SHPH cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$9.48M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$7.33M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$5.58M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$2.67M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$300K, share buybacks n/a
SHPH balance sheet
- Jun 30, 2026: cash $90.2K, total assets $22.8M, total liabilities $3.63M, shareholders' equity $19.2M
- Mar 31, 2026: cash $1.09M, total assets $11.8M, total liabilities $8.46M, shareholders' equity $3.35M
- Dec 31, 2025: cash $334K, total assets $10.5M, total liabilities $8.22M, shareholders' equity $2.25M
- Sep 30, 2025: cash $2.09M, total assets $3.54M, total liabilities $2.15M, shareholders' equity $1.39M
- Jun 30, 2025: cash $4.82M, total assets $5.50M, total liabilities $1.90M, shareholders' equity $3.61M
- Mar 31, 2025: cash $4.51M, total assets $5.31M, total liabilities $2.02M, shareholders' equity $3.29M
- Dec 31, 2024: cash $1.92M, total assets $2.51M, total liabilities $1.80M, shareholders' equity $709K
- Sep 30, 2024: cash $157K, total assets $674K, total liabilities $1.99M, shareholders' equity −$1.32M
Is SHPH profitable?
No. SHUTTLE PHARMACTCLS HLDGS IN lost $10.3M over the last four quarters.
What is SHPH's EPS?
Diluted earnings per share over the last four quarters were $29.82; −$3.10 in the latest quarter.